Cognition Therapeutics, Inc. Taxes Payable, Current
Cognition Therapeutics, Inc. (CGTX) had Taxes Payable, Current of $125.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:TaxesPayableCurrent · last filed 2022-05-11
- 2022-03-31: Taxes Payable, Current $125.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2022-03-31 | $125.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |